drugset / Trial / NCT04191629
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Single center, phase 1 study to evaluate the safety and tolerability of EO1404 in subjects with corneal edema secondary to pseudophakic bullous keratopathy or Fuch's endothelial dystrophy.
Timeline
- Start
- 2016-05-04
- Primary completion
- 2020-12-31
- Completion
- 2021-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EO1404 | Unknown | 50000 cells | — |
| Subject | EO1404 | Unknown | 200000 cells | — |
| Subject | EO1404 | Unknown | 500000 cells | — |